SEC Filing Form 4 for BIOLIFE SOLUTIONS INC

This filing details stock transactions by Todd Berard, Chief Marketing Officer of BIOLIFE SOLUTIONS INC (BLFS), on October 6, 2026. The transactions include the acquisition of 38,198 shares and 40,192 shares of common stock, with the price per share noted in footnotes F2 and F3 respectively, related to the vesting of restricted stock under the 2023 Omnibus Performance Incentive Plan. Additionally, 46,170 shares were disposed of with a price per share of $38.61 (footnote F4) and 194,786 shares were disposed of in connection with a merger (footnote F1). Following these transactions, the post-transaction shares owned are 156,589 and 0 respectively. The merger involved Bravo Merger Sub I, Inc. and resulted in each share of common stock being converted into $11.25 cash and 0.1442 shares of Repligen common stock.